Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some ...

Women who use an oral contraceptive might want to consider using a back-up method after starting a weight loss drug.

Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some ...

Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...

Experts say that semaglutide and tirzepatide can help patients with heart failure lose weight, but limited NHS access is ...

A new study found that weight-loss medications like Ozempic and Mounjaro are not as effective in a “real-world” setting ...

Eli Lilly's (LLY) experimental obesity drug, eloralintide, shows up to 11% weight loss in 12 weeks with minimal side effects in early-stage trial. Read more here.

GLP-1 investors haven’t gained as much as expected from others’ losses. Since the FDA approved Wegovy, also known as ...

Combining elements of four hormones into a single drug, researchers hope a next-generation weight loss drug will address not ...

Shares of weight-loss drug developer Metsera gained as much as 25% on Monday after the company's experimental drug helped patients lose weight in a small, early-stage trial, showing potential for a ...

Weight loss drugs like Ozempic and Wegovy are used by over 15 million adults in the U.S., or 4.5% of the population. Despite ...

Denmark-based multinational pharmaceutical company Novo Nordisk will be making available in the Philippines within this year ...